Literature DB >> 19372018

Differentiation of the regioisomeric 2-, 3-, and 4-trifluoromethylphenylpiperazines (TFMPP) by GC-IRD and GC-MS.

Hadir M Maher1, Tamer Awad, C Randall Clark.   

Abstract

Gas chromatography with infrared detection (GC-IRD) provides direct confirmatory data for the identification of the psychoactive designer drug 3-trifluoromethylphenylpiperazine (3-TFMPP) from the regioisomeric 2- and 4-trifluoromethylphenylpiperazines. These three regioisomeric substances are well resolved by GC and the vapor phase infrared spectra clearly differentiate among the three trifluoromethylphenyl substitution patterns. However, the mass spectra for the three regioisomeric 2-, 3-, and 4-trifluoromethylphenylpiperazines are identical and do not provide structural confirmation for one of the three isomers to the exclusion of the other two compounds. Perfluoroacylation of the secondary amine nitrogen for each of the three regioisomers was conducted in an effort to individualize their mass spectra. The resulting derivatives were resolved by GC and their mass spectra showed some differences in relative abundance of fragment ions without the appearance of any unique fragments for specific confirmation of structure.

Entities:  

Year:  2009        PMID: 19372018     DOI: 10.1016/j.forsciint.2009.03.009

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  2 in total

1.  GC-MS and GC-IRD studies on dimethoxyphenethylamines (DMPEA): regioisomers related to 2,5-DMPEA.

Authors:  Hadir M Maher; Tamer Awad; Jack DeRuiter; C Randall Clark
Journal:  J Chromatogr Sci       Date:  2012-01       Impact factor: 1.618

2.  Disubstituted piperazine analogues of trifluoromethylphenylpiperazine and methylenedioxybenzylpiperazine: analytical differentiation and serotonin receptor binding studies.

Authors:  Jack DeRuiter; Ashleigh Van Cleave; Audinei de Sousa Moura; Younis Abiedalla; C Randall Clark
Journal:  Forensic Sci Res       Date:  2018-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.